HAlejandroPretiMD

PubMed

• 40 citations
  Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.
  Jianguo Wen, Yongdong Feng, Wan Ting Huang, Haiyun Chen, Bing Liao
  Leukemia Research. 2010-01-01
• 21 citations
  Prognostic impact of C-REL expression in diffuse large B-cell lymphoma
  Choladda V. Curry, April A. Ewton, Randall J. Olsen, Brent R. Logan, Hector Alejandro Preti
  Journal of Hematopathology. 2009-02-13
• 24 citations
  Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
  Ahmed I. Younes, Hector Alejandro Preti, Fredrick B. Hagemeister, Patricia J. McLaughlin, J. E. Romaguera
  Annals of Oncology. 2001-07-01

Journal Articles

• Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition  
  Jianguo Wen, Yongdong Feng, Wanting Huang, Haiyun Chen,Bing Liao, Lawrence Rice, Rammurti T Kamble,Youli Zu, Douglas J Ballon, Chung-Che Chang, Leukemia research, 1/1/2009
• Prognostic impact of C-REL expression in diffuse large B-cell lymphoma  
  Curry CV, Ewton A, Olsen RJ, Logan B, Liu YC, Perkins SL and Chang CC, J Hematopathol, 1/1/2009
• Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma  
  Tsimberidou AM, McLaughlin P, Younes A, Rodriguez MA, Hagemeister FB, Sarris A, Romaguera J, Hess M, Smith TL, Yang Y, Ayala A, Lee MS, Cabanillas F, Blood, 1/15/2002
• A phase II study of paclitaxel/topotecan in patients with refractory and relapsing aggressive non-Hodgkin’s lymphoma  
  Younes A, et al., Ann Oncol, 1/1/2001
• Safety of Fludarabine, Mitoxantrone, Dexamethasone combined with Rituximab in the treatment of stage IV indolent lymphoma  
  McLaughlin P, Hagemeister FB, Rodriguez MA, Sarris AH, Pate O, Younes A, Lee MS, Dang NH, Romaguerra JE, McAda N, Cabanillas F, Semin Oncol, 1/1/2000
• Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin’s lymphoma after failure to cyt...  
  Romaguera JE, Rodriguez MA, Hagemeister FB, McLaughlin P, Rodriguez J, Younes A, Sarris AH, Cabanillas F, Invest New Drugs, 1/1/1999
• Interleukin-10 levels are often elevated in serum of adults with Hodgkin’s disease and are associated with inferior failure-free survival  
  Sarris AH, Klich KO, Pethambaram P, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andr..., Ann Oncol, 1/1/1999
• Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin’s lymphoma  
  Younes A, Romaguera J, Mesina O, Hagemiester F, Sarris AH, Rodriguez MA, McLaughlin P, Bachier C, Cabanillas F, Br J Haematol, 1/1/1998
• Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously unt...  
  Romaguera JE, Rodriguez Diaz-Pavon J, Carias L, Hagemeister FB, McLaughlin P, Rodriguez MA, Sarris AH, Younes A, Bachier C, Llerena E, Cabanillas F, Leuk Lymphoma, 1/1/1998
• Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin’s lymphoma  
  Romaguera JE, Hagemiester FB, McLaughlin P, Rodriguez MA, Bachier C, Sarris AH, Weber D, Younes A, Cabanillas F, Leuk Lymphoma, 1/1/1998
• High dose chemotherapy for relapsed and refractory primary mediastinal lymphoma  
  Popat U, van Besien K, Przepiorka D, Pugh W, Amin K, Giralt S, Romaguera, Rodriguez A, Andersson B, Mehra R, Khouri I, de Lima M, Gajewski J, Cabanillas F, and Champlin R, J Clin Oncol, 1/1/1998
• Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin’s lymphoma  
  Younes A, Rodriguez A, McLaughlin P, North L, Sarris, A, Pate O, Hagemeister F, Romaguera J, Preti A, Bachier C, and Cabanillas F, Leuk Lymphoma, 1/1/1997
• Use of the international prognostic index and the tumor score to detect poor risk patients with primary mediastinal large B-cell lymphoma: A study with 37 previously ...  
  Romaguera JE, Rodriguez J, Carías L, Bachier C, Hagemeister FB, McLaughlin P, Rodriguez MA, Sarris AH, Younes A, and Cabanillas F, J Clin Oncol, 1/1/1997
• Prognostic value of Interleukin-6 in Diffuse Large cell Lymphoma  
  Cabanillas F, Talpaz M, Seymour J, Tucker S, Kurzrock R, Ann Int Med, 1/1/1997
• Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial  
  Younes A, Ayoub JP, Sarris A, Hagemiester F, North L, Pate O, McLaughlin P, Rodriguez MA, Romaguera J, Kurzrock R, Bachier C, Smith T, Cabanillas F, Br J Haematol, 1/1/1997
• Incidence of Cytomegalovirus pneumonia in adult non-transplant cancer patients: Review of 9029 autopsies from 1964-1990  
  Mera JR, Whimbey E, Elting L, Luna M, Bruner JM, Williams TW, Bodey G, Goodrich JM, Journal of Infectious Disease, 1/1/1996
• Prognostic significance of positive myeloid markers in adult acute lymphocytic leukemia  
  Kantarjian HM, O'Brien S, Robertson L, Estey E, Beran M, Pierce S, Huh Y, Cancer, 1/1/1995
• Management of acute lymphocytic leukemia in adults  
  with Kantarjian HM, J Clin Oncol, 1/1/1994
• Acute lymphocytic leukemia (ALL) in the elderly: Characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen  
  Kantarjian HM, O'Brien S, Robertson L, Smith T, Estey E, Beran M, Pierce S, Keating M, Kantarjian H, British Journal of Hematology, 1/1/1994
• Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches  
  Hagemeister FB, McLaughlin P, Swan F, Rodriguez A, Besa P, Cox JD, Allen PK, Cabanillas F, Annals of Oncology, 1/1/1994
• Philadelphia chromosome positive adult acute lymphocytic leukemia - Characteristics, treatment results and prognosis  
  O'Brien S, Giralt S, Robertson L, Beran M, Koller C, Kantarjian H, Am J Med, 1/1/1994
• Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase positive blasts by electron microscopy  
  Kantarjian HM, Estey E, Keating M, Huh Y, Andreeff M, Pierce S, Hirsch-Ginsberg C, Yee G, Sanford Stass, Hematologic Pathology, 1/1/1994
• Join now to see all

Books/Book Chapters

• Primary Care Oncology 
  Chapter: Hodgkin’s Disease 
  with Seigler DW. B. Saunders1996
• Primary Care Oncology 
  Chapter: Non-Hodgkin’s Lymphoma 
  with Ritty AW. B. Saunders1996
• Cancer Bull 
  Chapter: Lymphoma in the elderly 
  Page 192 - 196with Cabanillas FC1995
• Medico Interamericano 
  Chapter: Linfoma en Pacientes de Edad Avanzada 
  Page 281 - 285Preti, A1995
• Texas Medicine 
  Chapter: Acute lymphocytic leukemia in adults: an update 
  Page 52 - 59with Kantarjian HM1994
• Medical Oncology a Comprehensive Review 
  Chapter: Testicular cancer 
  Page 295 - 311with Logothetis CJPRR, Huntington, New York1993
• The Non-Hodgkin's Lymphomas 
  Chapter: Cabanillas F 
  with Cabanillas FEditors: Ian T. Magrath.ArnoldEdition 2nd,1993
• Join now to see all

Abstracts/Posters

• Assessment of safety with abbreviated, weight-based bevacizumab infusions
  Hart J, Oholendt M, American Society of Clinical Pharmacology Annual Meeting, 1/1/2007
• Hypercalcemia caused by parathyroid hormone-related protein and ectopic production of intact parathyroid hormone in a patient with multiple malignancies
  Eid W, Wheeler TM, Sharma MD, Endo 2000 The Endocrine Society 82nd Annual Meeting, 1/1/2000
• Hodgkin’s disease: Prognostic factors, including IL-10: A model for pathogenesis and a guide to therapy
  Sarris AH, Kliche KO, Smith T, Mesina O, Hagemeister F, McLaughlin P, Romaguera J, Rodriguez MA, Pugh W, Fuller L, Ha C, Cox J, Andreff M, Cabanillas F, International J of Oncology, 1/1/1997
• Prognostic models for adults with Hodgkin’s disease (HD) treated with chemotherapy at M. D. Anderson
  Sarris AH, Messina O, Santiago M, Smith T, Hagemeister F, McLaughlin P, Rodriguez MA, Romaguera J, Ha C, Cox J, Pugh W, Cabanillas F, Proceeding of the American Society of Hematology, San Diego, 1/1/1997
• Stage IV low grade lymphoma (LGL): Randomized trial of two innovative regimens, with monitoring of bcl-2 by PCR
  McLaughlin P, Cabanillas, Younes A, Lee MS, Rodriguez MA, Hagemeister F, Sarris AH, Proceeding of the Sixth International Conference on Malignant Lymphoma, Lugano, Switzerland, 1/1/1996
• Paclitaxel (Taxol): An active new drug for the treatment of Non-Hodgkin’s Lymphoma (NHL)
  Younes A, Ayoub JP, Sarris AH, Hagemeister F, McLaughlin P, Rodriguez MA, Romaguera J, Bachier C, Cabanillas F, Proceeding of the Sixth International Conference on Malignant Lymphona, Lugano, Switzerland, 1/1/1996
• Phase II trial of infusional taxol and high dose cytoxan with granulocyte colony stimulatin factor (Filgrastim) for the treatment of relapsed/refractory intermediate g...
  Younes A, Romaguera J, Sarris A, North L, Hagemeister F, McLaughlin P, Rodriguez MA, Cabanillas F, Proceedings of the American Society of Clinical Oncology, 1/1/1996
• Serum b2-Microglobulin: An Important Prognostic Factor for Patients (PT) with Clinical-Staged (CS) I-II Hodgkin’s Disease (HD) Treated with NOVP and Radiotherapy (XT)
  Hagemeister F, Cox J, McLaughlin P, Rodriguez MA, Romaguera J, Younes A, Sarris A, Bachier C, Cabanillas F, Third International Symposium on Hodgkin’s Lymphoma, 1/1/1995
• The pretreatment serum beta-2 microglobulin is the most important feature predicting freedom from progression in clinically staged I-II Hodgkin’s disease treated wtih...
  Hagemeister FB, Mc Laughlin P, Rodriguez MA, Cox JD, Ha CS, Romaguera JE, Sarris AH, Younes A, Bachier C, Cabanillas F, Blood, 1/1/1995
• Preliminary results of a Phase II trial of topotecan in patients with relapsing lymphoma
  Plunkett W, Sarris AH, Younes A, Hagemeister F, Rodriguez MA, Romaguera J, Mc Laughlin P, Bachier C, Cabanillas F, Blood, 1/1/1995
• Interleukin-6 as a prognostic factor in diffuse large-cell lymphoma: A multivariate analysis
  Talpaz M, Cabanillas F, Seymour J, Tucker S, Kurzrock R, Blood, 1/1/1995
• Philadelphia chromosome-positive adult acute lymphocytic leukemia - characteristics, treatment results, and prognosis
  O'Brien S, Giralt S, Robertson L, Beran M, Koller C, Kantarjian H, Blood, 1/1/1993
• Use of the International Prognostic Index (IPI) and the Tumor Score (TS) to detect poor-risk patients with primary mediastinal large B-cell lymphoma (PMLCL): A study w...
  Romaguera J, Rodriguez Diaz-Pavon J, Carias L, Hagemeister FB, McLaughlin P, Rodriguez MA, Sarris AH, Younes A, Llerena E, Cabanillas F, Proceedings of the Sixth International Conference on Malignant Lymphona, Lugano, Switzerland, 1/1/1993
• B2-microglobulin is capable of improving the prognostic discrimination of international index
  Swan F, Hagemeister F, McLaughlin P, Rodriguez M, Cabanillas F, Blood, 1/1/1993
• Characteristics and outcome of patients with acute lymphocytic leukemia (ALL) and myeloperoxidase positive blasts by electon microscopy (EM-MPO-positive)
  O'Brien S, Robertson L, Beran M, Huh Y, Koller C, Hirsch-Ginsberg C, Andreeff M, Stass S, Kantarjian H, Blood, 1/1/1993
• Prognostic significance of positive myeloid markers in adult acute lymphocytic leukemia
  Huh Y, O'Brien S, Robertson L, Estey E, Beran M, Pierce S, Keating M, Kantarjian H, Blood, 1/1/1993
• Acute ,lymphocytic leukemia (ALL) in the elderly: Characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen
  O'Brien S, Robertson L, Smith T, Estey E, Beran M, Pierce S, Keating M, Kantarjian H, Blood, 1/1/1993
• New approaches in the treatment of Hodgkin's disease
  with Hagemeister FB, XVth Argentine Society of Hematology Meeting, 1/1/1993
• Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches
  Hagemeister FB, McLaughlin P, Swan F, Rodriguez A, Besa P, Cox JD, Allen PK, Cabanillas F, Fifth International Conference on Malignant Lymphona, Lugano, Switzerland, 1/1/1993
• Incidence of Cytomegalovirus pneumonia in adult non-transplant cancer patients: Review of 9549 autopsies from 1964-1990
  Mera JR, Whimbey E, Luna M, Elting L, Vartivarian S, Williams TW, Bodey G, ICAC Meeting, Annaheim, 1/1/1992
• Activity of Taxol and high-dose Cytoxan with granulocyte colony stimulating factor (G-CSF) in 54 patients with relapsed/refractory intermediate grade non-hodgkin;s lym...
  Younes A, Romaguera J, North L, Messina O, Hagemeister F, Sarris A, McLaughlin P, Rodriguez MA, Cabanillas F, Proceeding of the American Society of Clinical Oncology
• Intensive reinduction with high-dose ifosfamide/VP16 and ifosfamide/novantrone followed by BEAM and stem cell transplant for recurrent lymphoma (NHL)
  van Besien K, Rodriguez MA, Amin K, Mehra R, Romaguera J, Giralt S, McLaughlin P, Andersson B, Hagemeister F, Gajewski J, Sarris A, Przepiorka D, Mirza N, Younes A, Ba..., Proceeding of the American Society of Clinical Oncology
• Join now to see all